<html>
<head>
<title>
Covaxin by Bharat BioTech
</title>
</head>

<body background=assets/vaccine3/covaxin2.jpg>

<font face=calibri body>

<h2>COVAXIN速 - India's First Indigenous COVID-19 Vaccine</h2>

<b>

<p>
<img src=assets/vaccine3/covaxin.jpg align=right height=200 width=350>
<div align=justify>

COVAXIN速, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).

</div>
</p>

<p>
<div align=justify>

The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.

</div>
</p>

<p>
<div align=justify>

The vaccine is developed using Whole-Virion Inactivated Vero Cell derived platform technology. Inactivated vaccines do not replicate and are therefore unlikely to revert and cause pathological effects. They contain dead virus, incapable of infecting people but still able to instruct the immune system to mount a defensive reaction against an infection.

</div>
</p>

<p>
<img src=assets/vaccine3/covaxin4.gif align=left height=200 width=350>
<div align=justify>

Why develop Inactivated Vaccine? Conventionally, inactivated vaccines have been around for decades. Numerous vaccines for diseases such as Seasonal Influenza, Polio, Pertussis, Rabies, and Japanese Encephalitis use the same technology to develop inactivated vaccines with a safe track record of >300 million doses of supplies to date. It is the well-established, and time-tested platform in the world of vaccine technology.

</div>
</p>

<br>
<br>
<br>
<br>

<p>
<img src=assets/vaccine3/covaxin3.jpg align=right height=200 width=350>
<div align=justify>
<br>
Global Acceptance of COVAXIN速:

<br>
<br>

Bharat biotech has been approached by several countries across the world for the procurement of COVAXIN速.

<br>
<br>

Clinical trials in other countries to commence soon.

<br>
<br>

Supplies from government to government in the following countries to take place:Mongolia, Myanmar, Sri Lanka, Philippines, Bahrain, Oman, Maldives and Mauritius.

<br>
<br>

Source:		<a href=https://www.bharatbiotech.com/covaxin.html>	www.bharatbiotech.com/covaxin.html		</a>
<br>
		<a href=vaccine2.html>			<img src=assets/buttons/leftarrow.png align=left height=41 width=41>		</a>

		<a href=vaccine4.html>			<img src=assets/buttons/rightarrow.png align=right height=50 width=50>		</a>
	<div align=center>
		<a href=home.html>			<img src=assets/buttons/homebutton.png align=center height=50 width=100>	</a>
	</div>
</div>
</p>


</b>
</font>
</body>
</html>